CLDN5 and neoplasm: Cldn5 inhibition lead to an increase in vascular permeability to gadolinium across the brain (Fig. 6, H and I), with a noticeable increase in CD8α+ cell influx into the tumor microenvironment (Fig. 6, J and K).